Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cells

Study protocol for an open-label, singlearm, phase Ib/II study of combination of toripalimab, nab-paclitaxel, and gemcitabine as the first-line treatment for patients with unresectable pancreatic ductal adenocarcinoma

8 p | 19 | 4

Dentinogenic ghost cell tumor treated with a combination of marsupialization and radical resection: A case report and review of the literature

9 p | 3 | 2

Modified Lemaire extra-articular stabilisation of the knee for the treatment of anterolateral instability combined with diffuse pigmented villonodular synovitis: A case report

6 p | 9 | 2

Patient characteristics and short-term effectiveness of shortacting bronchodilator combination of salbutamol/ipratropium in patients with chronic obstruction pulmonary disease (COPD): A cross-sectional multicenter study in Viet Nam

7 p | 3 | 2

Combining gene expression analysis of gastric cancer cell lines and tumor specimens to identify biomarkers for anti-HER therapies— the role of HAS2, SHB and HBEGF

17 p | 5 | 1

Longitudinal profiling of gut microbiome among tuberculosis patients under antituberculosis treatment in China: Protocol of a prospective cohort study

9 p | 6 | 1

Discriminative motif finding to predict HCV treatment outcomes with a semi-supervised feature selection method

11 p | 9 | 1

Effect of laser acupuncture combined with a diet-exercise intervention on metabolic syndrome in post-menopausal women

7 p | 26 | 0

Up-regulation of HER2 by gemcitabine enhances the antitumor effect of combined gemcitabine and trastuzumab emtansine treatment on pancreatic ductal adenocarcinoma cells

9 p | 12 | 0